AO

Actis Oncology clinical programs

Topic

Expert statements

1

What experts have said about Actis Oncology clinical programs

1 statement · 1 neutral

  1. Actis expects initial data from its Nectin4 and B7H3 programs in 2027

    “publicly guided to initial clinical data in both of these lead programs in 2027”

    Listen at 32:38

    Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Actis Oncology clinical programs · PodLume